Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 4: Neurotherapeutics & Pain
Submit an article Journal homepage
1,136
Views
7
CrossRef citations to date
0
Altmetric
Neurotherapeutics

Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome

Michael Cronquist ChristensenH. Lundbeck A/S, Valby, Denmark; Correspondence[email protected]
&
Vicki MunroSynergy Health Economics Limited, London, UK
Pages 593-600 | Received 08 Sep 2017, Accepted 08 Dec 2017, Published online: 16 Jan 2018

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dorota Danielak. (2021) Vortioxetine in management of major depressive disorder – a favorable alternative for elderly patients?. Expert Opinion on Pharmacotherapy 22:9, pages 1167-1177.
Read now
Gang Wang, Kun Zhao, Caroline Reynaud-Mougin, Henrik Loft, Hongye Ren, Hanne-Lise F. Eriksen & Anders Ettrup. (2020) Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder. Current Medical Research and Opinion 36:5, pages 875-882.
Read now

Articles from other publishers (5)

Richard Dodel, Christopher Kruse, Annette Conrads-Frank & Uwe Siebert. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 101 234 .
Daniela Adamo, Elena Calabria, Noemi Coppola, Giuseppe Pecoraro & Michele Davide Mignogna. (2021) Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update. Therapeutic Advances in Psychopharmacology 11, pages 204512532110343.
Crossref
Aleksander Nobis, Daniel Zalewski & Napoleon Waszkiewicz. (2020) Peripheral Markers of Depression. Journal of Clinical Medicine 9:12, pages 3793.
Crossref
Cecilia Maria Esposito & Massimiliano Buoli. (2020) The biological face of melancholia: Are there any reliable biomarkers for this depression subtype?. Journal of Affective Disorders 266, pages 802-809.
Crossref
Richard Dodel, Christopher Kruse, Annette Conrads-Frank & Uwe Siebert. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 135 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.